Currently, IL-15 antagonizing antibodies (e.g., AMG 714) have demonstrated efficacy in treating autoimmune diseases such as celiac disease and ankylosing spondylitis (22), supporting their potential application in vitiligo. Here, IL15 is linked to autoimmune disease.